Updated with Exclusive | ESMO 2018: 60% of Ovarian Cancer Patients Receiving Lynparza Were Progression-Free at 3 Years 글 내용 전체보기
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure 글 내용 전체보기
AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells 글 내용 전체보기